Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Stem Cells Translational Medicine is Scopus-indexed (Q1, CiteScore 10), WoS SCIE, DOAJ. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2157-6564Verify ISSN ↗2157-6580Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Developmental Biology | 7 / 78 | 91st | Q1 |
| Cell Biology | 55 / 289 | 81st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 10.
Stem Cells Translational Medicine is Q1 in Developmental Biology (rank 7 of 78) and Q1 in Cell Biology (rank 55 of 289), by CiteScore 2025.
Stem Cells Translational Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.588, quartile Q1, with an H-index of 116.
The publisher lists an article processing charge of about US$2,963 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Stem Cells Translational Medicine is published by Oxford University Press. Its print ISSN is 2157-6564 and its online ISSN is 2157-6580.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Stem Cells Translational Medicine has an h-index of 133 and a 2-year mean of 4.53 citations per paper (OpenAlex). Its Scopus CiteScore is 10, quartile Q1. On 2-year citations it ranks #21 of 76 Scopus journals in Developmental Biology.
Stem Cells Translational Medicine published 86 papers in 2025; its busiest recent year was 2020 with 218. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from China (29.6%), United States (21.3%) and South Korea (10.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.